Nice to hear an optimistic take and hopefully this is the one that comes to life. However, on this bit: "every OT partner to date for Galan has been met with undue criticism" I think these critiques were fair, not 'undue'. I have never seen a junior enter a deal with Glencore and come out the winner. They are the savviest of sharks as anyone who has read about them will know (JP signed a binding offtake in return for nothing more than an 'offer' to finance the project). Chemphys are/were relatively unknown, posters could only find one other lithium deal they'd been involved in which is unusual for a company that were going to stump up US$40M in funding. As for Authium and this deviation from 3+ years of formal studies (July 2020 to October 2023), I think this part of the presentation outlines the issue quite cleanly:
Galan has gone from a robustly-studied approach using conventional pond/liming/evap approach to a novel DLE technology based on some samples being tested at a Sydney laboratory in March. Anyone who has listened to JP's numerous conferences over the years knows he was a fierce proponent of conventional ponds over DLE, so this is a big U-turn. Given it's now their third offtake/funding partner it's not hard to come to the conclusion that they were desperate to get a deal over the line.
- Forums
- ASX - By Stock
- GLN
- Ann: HMW Phase 1 Funding & Offtake Secured with US Based Partner
GLN
galan lithium limited
Add to My Watchlist
4.26%
!
9.8¢

Ann: HMW Phase 1 Funding & Offtake Secured with US Based Partner, page-132
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.8¢ |
Change
0.004(4.26%) |
Mkt cap ! $98.19M |
Open | High | Low | Value | Volume |
9.5¢ | 10.5¢ | 9.5¢ | $343.2K | 3.463M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 223267 | 9.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 1090592 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 223267 | 0.098 |
2 | 170000 | 0.097 |
2 | 491000 | 0.096 |
1 | 10000 | 0.095 |
2 | 150000 | 0.094 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 1090592 | 16 |
0.110 | 1276650 | 21 |
0.115 | 1021249 | 16 |
0.120 | 1177837 | 7 |
0.125 | 317018 | 5 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
GLN (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online